Showing results (121-130 of 207) with videos related to

Sort By:
Pageof 21
Pharmacogenomics|April 1, 2015
Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20(+) B-cell lymphomaAnnegret Reichwagen, Marita Ziepert, Markus Kreuz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 13, 2011
Docking of lytic granules at the immunological synapse in human CTL requires Vti1b-dependent pairing with CD3 endosomesBin Qu, Varsha Pattu, Christian Junker, et al.
Blood|January 12, 2011
Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemiaSandra Grass, Klaus-Dieter Preuss, Alexandra Wikowicz, et al.
International Journal of Cancer|March 3, 2007
The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancerInka Seil, Claudia Frei, Holger Sültmann, et al.
European Journal of Immunology|June 15, 2007
MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processingGerhard Held, Andreas Wadle, Nina Dauth, et al.
Blood|February 26, 2004
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHLMichael Pfreundschuh, Lorenz Trümper, Marita Kloess, et al.
Blood|September 19, 2013
High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysisDaniel Fürst, Carlheinz Müller, Vladan Vucinic, et al.
Frontiers in Oncology|December 7, 2020
Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS LymphomaMoritz Bewarder, Maximilian Kiefer, Clara Moelle, et al.
Blood|June 19, 2014
The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomasNiels Murawski, Gerhard Held, Marita Ziepert, et al.
Annals of Hematology|September 3, 2024
An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphomaKonstantinos Christofyllakis, Dominic Kaddu-Mulindwa, Vadim Lesan, et al.
Pageof 21